NPC(SH:600713) Shang Hai Zheng Quan Bao·2025-11-11 19:27Core Points - The company, Nanjing Pharmaceutical Co., Ltd., announced the second extraordinary general meeting of shareholders for 2025, scheduled for November 19, 2025 [1] - The meeting will utilize a combination of on-site and online voting methods [1][2] - The company will remind small and medium-sized investors to participate in the voting through SMS notifications [6] Meeting Details - Meeting Date: November 19, 2025, at 14:00 [1] - Location: Conference Room, 8th Floor, Building 2, No. 55, Andemen Street, Yuhuatai District, Nanjing [1] - Voting Methods: On-site voting and online voting via the Shanghai Stock Exchange system [1][2] Voting Procedures - Online voting will be available on the day of the meeting from 9:15 to 15:00 [2] - Shareholders can vote through the trading system or the internet voting platform [5] - Multiple accounts held by a shareholder will allow them to aggregate their voting rights [6] Agenda Items - The meeting will review several proposals, including special resolutions and separate voting for small and medium-sized investors [5] - The proposals were previously approved by the board on October 29, 2025 [4] Attendance - Eligible attendees include shareholders registered by the close of trading on the registration date, company directors, supervisors, and appointed lawyers [10] - Registration for attendance will occur on November 18, 2025 [12][13] Financial Management - The company approved the use of up to 700 million yuan of temporarily idle raised funds for cash management, investing in low-risk financial products [17] - A specific investment of 60 million yuan in a structured deposit product yielded a return of 247,200 yuan upon redemption [18]